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Background. The whole blood interferon-gamma assay (QuantiFERON-TB-2G; QFT) has not been fully evaluated as a baseline
tuberculosis screening test in Japanese healthcare students commencing clinical contact. The aim of this study was to compare
the results from the QFT with those from the tuberculin skin test (TST) in a population deemed to be at a low risk for infection
with Mycobacterium tuberculosis. Methodology/Principal Findings. Healthcare students recruited at Okayama University
received both the TST and the QFT to assess the level of agreement between these two tests. The interleukin-10 levels before
and after exposure to M tuberculosis-specific antigens (early-secreted antigenic target 6-kDa protein [ESAT-6] and culture
filtrate protein 10 [CFP-10]) were also measured. Of the 536 healthcare students, most of whom had been vaccinated with
bacillus-Calmette-Gue ´rin (BCG), 207 (56%) were enrolled in this study. The agreement between the QFT and the TST results was
poor, with positive result rates of 1.4% vs. 27.5%, respectively. A multivariate analysis also revealed that the induration
diameter of the TST was not affected by the interferon-gamma concentration after exposure to either of the antigens but was
influenced by the number of BCG needle scars (p=0.046). The whole blood interleukin-10 assay revealed that after antigen
exposure, the median increases in interleukin-10 concentration was higher in the subgroup with the small increase in
interferon-gamma concentration than in the subgroup with the large increase in interferon-gamma concentration (0.3 vs. 0 pg/
mL; p=0.004). Conclusions/Significance. As a baseline screening test for low-risk Japanese healthcare students at their
course entry, QFT yielded quite discordant results, compared with the TST, probably because of the low specificity of the TST
results in the BCG-vaccinated population. We also found, for the first time, that the change in the interleukin-10 level after
exposure to specific antigens was inversely associated with that in the interferon-gamma level in a low-risk population.
Citation: Hotta K, Ogura T, Nishii K, Kodani T, Onishi M, et al (2007) Whole Blood Interferon-Gamma Assay for Baseline Tuberculosis Screening among
Japanese Healthcare Students. PLoS ONE 2(8): e803. doi:10.1371/journal.pone.0000803
INTRODUCTION
Tuberculosis continues to be a heavy burden on human health [1].
Especially, healthcare workers are at increased risk of infection
because of occupational exposure to tuberculosis patients,
although in Japan this risk is lower than in the low- and middle-
income countries [2–4]. Indeed, female nurses have a risk for
developing active tuberculosis that is two-fold higher than that of
the general population in Japan (odds ratio of 2.3) [5]. One of the
important component of tuberculosis infection control is the
routine screening of healthcare workers for latent tuberculosis
infection and the administration of chemoprophylaxis to those
who test positive. The tuberculin skin test (TST) has been the only
practical means for this purpose in the past century.
At Okayama University Hospital, tuberculosis patients are
incidentally referred to the hospital before a definite diagnosis has
been confirmed, even though the hospital does not have
a tuberculosis-specific ward. Thus, not only healthcare workers,
but also healthcare students studying at our hospital are at risk of
tuberculosis exposure.Asaninfectioncontrolpolicy,a TSTmustbe
taken by all healthcare students and is optional for first-year
postgraduate students prior to the start of clinical training, similar to
the policies of many other medical universities [6]. The main
purpose for performing a TST in this situation is to identify the
baseline immune status of the healthcare students in case of future
contact with tuberculosis patients, rather than screening for latent
tuberculosis infection, because of the very low estimated prevalence
of tuberculosis infection among young people in Japan [7].
Unfortunately, the TST has several major limitations; one of them
is the possible occurrence of false-positive test results in individuals
vaccinated with bacillus-Calmette-Gue ´rin (BCG) [8]. Especially, after
the initial vaccination at birth, the majority of the Japanese
population has been repeatedly vaccinated with BCG until recently,
during childhood if a negative TST result was obtained when
attendingprimary and junior highschool.Suchrepeated vaccinations
can lead to a significant and persistent influence of BCG on TST
results [9]. Therefore, this limitation is quite problematic in Japan,
especially for the precise detection of subjects without tuberculosis
infections. Recently, a whole blood interferon-gamma assay has been
introduced for the diagnosis of latent tuberculosis infection and active
tuberculosis; this assay is based on a specific elevation in the
interferon-gamma concentration that occurs as T cells respond to
early-secreted antigenic target 6-kDa protein (ESAT-6) and culture
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by Mycobacterium tuberculosis but not by BCG strains. Recent studies
have shown that this blood assay has a moderate sensitivity for the
detection of latent tuberculosis infection in the range of 70–80%, but
ishighlyspecific(over95%)ascomparedwiththeTSTeveninBCG-
vaccinated patients with varying risks of infection with Mtuberculosisor
active tuberculosis [8,10]. Thus, for our healthcare students–most of
who had been vaccinated with BCG, had not yet started bed-side
training, and were at low risk for tuberculosis infection–a more
accurate identification of their baseline immune status might be
obtained using this blood test, rather than the TST. However, the
usefulness of this assay as a baseline screening test for healthcare
students at the time of their entry into clinical studies has not been
fully evaluated in Japan. Here, we prospectively compared the
accuracy of the whole blood interferon-gamma assay with that of the
traditional TST in healthcare students thought to be at a low risk of
infection with M tuberculosis.
Unlike Th1-mediated cytokines such as interferon-gamma that
promote the killing of infected cells, regulatory cytokines including
interleukin-10 have been implicated in the suppression of in vitro
antigen-specific cellular immune responses in tuberculosis. Their
down-regulatory mediators may be important players in control-
ling the excessive synthesis of pro-inflammatory cytokines and
subsequent tissue damage [11]. However, few studies have
reported how such Th2 mediators respond after stimulation with
ESAT-6 and CFP-10 antigens, and all of these studies were
conducted in mice and calves [12,13], not in human subjects.
Therefore, we also investigated the potential influence of these
specific antigens on the interleukin-10 concentration as well as the
interferon-gamma concentration, and assessed the association
between changes in the concentrations of these two cytokines
when exposed to the above two antigens.
METHODS
Participants
AllparticipantsinthistrialwereprospectivelyrecruitedatOkayama
University, Japan, between May and July, 2006. The subjects
consisted of medical, nursing and dental students who were enrolled
at the beginning of their clinical training, all of who were older than
18 years of age. First-year postgraduate students were also
recruited. Subjects who received both whole blood assay and
TST were considered to be eligible for this study. The protocol was
approved by the ethics review committee of Okayama University.
After providing written consent, the subjects wereasked to complete
a questionnaire about possible risk factors for exposure to M
tuberculosis. The following data were collected: history of prior
tuberculosis or exposure to a person with tuberculosis, and other
tuberculosis risk factors like having an immunosuppressive condi-
tion (i.e., malignant disease or diabetes mellitus) or having taken
immunosuppressive drugs in the 3 months prior to enrollment.
Information regarding any clinical symptoms, previous TST results,
BCG vaccination status (as reported by the prescribing physician
and based on questions about past BCG vaccination and scar
inspection), and demographic, clinical, and radiological data was
also collected at the time of enrollment. Human immunodeficiency
virus testing was not performed because of the low prevalence of
positive human immunodeficiency virus expected in this young,
educated population.
Test methods—TST and whole blood interferon-
gamma assay
For the TST, 0.1 mL of tuberculin purified protein derivative
(PPD) (Nippon BCG Manufacturing, Tokyo, Japan; equivalent to
about 3 TU of PPD-S) was injected intradermally into the volar
aspect of the forearm and the transverse induration diameter was
measured 48 hours later, as described previously [14]. A one-step
TST was then performed.
The whole blood interferon-gamma assay was performed using
the QuantiFERON-TB-2G (Nippon BCG Supply, Japan) as
described elsewhere [14], principally one month after the TST. A
heparinized blood sample was collected from each subject by
venipuncture. After overnight incubation with saline (nil control),
phytohemagglutinin (mitogen-positive control), and the M tubercu-
losis-specific antigens ESAT-6 or CFP-10, the concentration of
interferon-gamma inthe four plasmasamplesfrom eachsubjectwas
determined using an ELISA. We interpreted the test results, after
subtracting the value of the negative control well from the IU
amount of interferon-gamma measured in the wells stimulated by
the M tuberculosis-specific antigens as follows: positive if the
interferon-gamma concentration in either of the antigen wells was
$0.35 IU/mL; negative if the concentrations in both antigen wells
were ,0.35 IU/mL and the concentration in the positive control
well was $0.5 IU/mL; and indeterminate if the concentration in
both antigen wells was ,0.35 IU/mL and the concentration in the
positive control well was ,0.5 IU/mL in the positive-control well.
The technicians performing the whole blood interferon-gamma
assay had already been trained by the manufacturers and were
unaware of the subjects’ tuberculosis status in this study.
Test methods—Whole blood interleukin-10 assay
We measured the protein level of interleukin-10 in whole blood
incubated overnight with antigens, using an ELISA kit (Biosource,
Camarillo, California, USA). This assay also involved the same
two steps; after the blood samples were separately incubated with
CFP-10 and ESAT-6 and the nil and mitogen (phytohemagglu-
tinin) controls for 18 hours at 37uC, the concentration of
interleukin-10 in the four plasma samples from each subject was
determined using an ELISA. The detection limit for interleukin-10
was ,0.1 pg/mL. The results for ESAT-6 and CFP-10 were
expressed as the detected concentration of interleukin-10 minus
the concentration of interleukin-10 in the respective nil control
plasma. This blood assay was also performed in a blind manner.
Statistical methods
Agreement between the tests was quantified using the k statistic. A
logistic regression analysis for positive TST results (indura-
tion$15mm) and for positive blood assay results was performed
to adjust the potential confounding factors including age, prior
tuberculin skin test, number of BCG scars, student category and
increase in the interleukin-10 concentrations when exposed to
either of the antigens. The Mann-Whitney U test was used for
comparisons among groups. Because our goal was to recruit all
healthcare students commencing clinical training, we did not
determine a formal sample size. All p-values were two-sided, and
significance was set at a p-value of #0.05.
RESULTS
Demographics of the participants
Of the 536 students to whom the outline of this study was
announced(Fig 1),371 (69%)underwenttheTST; ofthesestudents,
207 (56%) subjects also underwent the whole blood interferon-
gamma assay, after providing their written informed consent. The
demographics of the207participants arelistedinTable 1.Only one
of the 207 subjects had an obvious episode of close contact with
a tuberculosis patient. This subject was a healthy 25-year-old
nursing student who had been vaccinated with BCG soon after his
IFN c Assay for TB screening
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with him, contracted pulmonary tuberculosis and died. None of the
family members who had been living with this patient have since
developed tuberculosis,although their TST results at the time of the
grandfather’s death were not available. None of the subjects
enrolled in this study reported having an immunosuppressive
condition. The majority of the subjects had last been screened with
the TST when entering junior high school.
Comparison of the TST and whole blood interferon-
gamma assay results
No treatments or interventions were undergone in the intervals
betweenbothtests.Thetwotestsweresafelyconductedinallpatients.
Regarding the TST results, 171 subjects (82.6%) had an induration
diameter of $5 mm, 124 (59.9%) had an induration diameter of
$10 mm, and 57 (27.5%) had an induration diameter of $15 mm.
The distribution of induration diameters is displayed in Fig 2. Three
subjects (1.4%) had a strong reaction in addition to a large induration
diameter (18 mm, 18 mm, and 15 mm), with obvious hemorrhaging
in two subjects and vesicles in one subject. One of the three subjects
had previously been in close contact with a tuberculosis patient, as
mentioned above; since then, he had consistently exhibited a similar
strong skin reaction whenever he received a TST, although his whole
blood test was negative (ESAT-6: 0.03 IU/mL; CFP-10: 0.00 IU/
mL). The other two subjects did not have relevant clinical symptoms,
a history of close contact with a tuberculosis patient, or abnormal
shadows on chest X-rays taken at the time of this study. These two
subjects had received BCG vaccinations during childhood and had
negative whole blood test results (ESAT-6: 0.00 IU/mL and
0.00 IU/mL; CFP-10: 0.03 IU/mL and 0.00 IU/mL).
Regarding the whole blood interferon-gamma assay (Fig 1),
five subjects (2.4%) had indeterminate results because of insuffi-
cient interferon-gamma production in response to the mitogen.
These indeterminate results were also used for the comparison of
the two tests based on the entire sample data. The median baseline
concentration of interferon-gamma (negative control) was 0.07
IU/mL (range, 0.01 to 0.79 IU/mL), while the median increase
in the interferon-gamma concentration after exposure to either of
the antigens was 0.01 IU/mL (range, 0 to 1.89 IU/mL). Three
subjects (1.4%) had positive blood test results (ESAT-6: 0.40 IU/mL,
0.37 IU/mL, and 1.89 IU/mL; CFP-10: 0.47 IU/mL, 1.26 IU/mL,
Figure 1. A flow diagram of the whole blood interferon-gamma assay in the 207 subjects.
doi:10.1371/journal.pone.0000803.g001
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(induration of 15 mm each). None of these subjects had relevant
clinical symptoms, a history of recent close contact with a tuberculosis
patient, or abnormal shadows on chest X-rays taken at the time of this
study.TwoofthethreesubjectshadbeenvaccinatedwithBCGduring
childhood,whilethethirdhadapositiveTSTtestatbirthandwasthus
considered to have had a tuberculosis infection despite not having had
an obvious episode of exposure to a person with tuberculosis or a BCG
vaccination.
Considering abovementioned two subjects would have previous
episodes of tuberculosis infections (the first case with the strong TST
reaction and the third case with the positive blood test result), the
specificity of blood assay was calculated as 96.6% (198/205) (Fig 1).
Regarding TST with a cutoff of induration diameter of $5, $10
and $15 mm, the specificity was 17.6%, 40.5% and 73.2%,
respectively.In contrast,sensitivity was not assessed because ofa few
subjects with obvious tuberculosis disease in our study. The
association between the diameter of the TST induration and the
positive whole blood interferon-gamma assay result is shown in
Table 2. Using cutoff levels of an induration diameter of $5, $10
and $15 mm for the TST and $0.35 IU/mL for the whole blood
assay, the overall agreement between the two tests was 18.8%,
41.1% and 72.5% (k=0.007, 0.020 and 0.077), respectively. A
logistic regression analysis also revealed that the diameter of the
TST induration ($15 mm vs. ,15 mm) was not affected by the
interferon-gamma concentration after exposure to either of the
antigens (odd ratio=1.441, 95% confidence interval=0.737–
2.818; p=0.285), but was influenced by the number of needle
scars from the BCG vaccination (odd ratio=3.857; 95% confidence
interval=1.022–14.555; p=0.046). In contrast, the whole blood
assay result was not affected by the number of BCG scars (odd
ratio=0.905; 95% confidence interval=0.207–3.958; p=0.894).
Whole blood interleukin-10 assay
This assay was assessable for all 207 subjects. The median baseline
concentration of interleukin-10 (negative control) was 2.9 pg/mL
(range: 0.2 to 39.9 pg/mL). This value was not associated with the
Table 1. Demographics of 207 participants
......................................................................
Gender (male/female) 75 (36%)/132 (64%)
Median age (range) 20 (18–42)
Student groups
Medical students 42 (20%)
Nursing students 107 (52%)
Dental students 44 (21%)
Postgraduate students 14 (7%)
Prior tuberculin skin test
Yes/No 193 (93%)/14 (7%)
Number of prior BCG vaccinations
0/1/2/3/4 3(1%)/91(44%)/79(38%)/10(5%)/10(5%)
Unknown 14 (7%)
Median age of subjects at which BCG was finally vaccinated (range)
7 (0–16)
Abbreviation: BCG=bacillus-Calmette-Gue ´rin.
doi:10.1371/journal.pone.0000803.t001
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Figure 2. Distribution of tuberculin skin test and whole blood interferon-gamma assay results among 207 subjects. The bars for 15 mm and
18 mm included one and two subjects, respectively, with strong skin reactions (i.e., vesicles and hemorrhage) to the purified protein derivative (*).
Three additional subjects with positive whole blood interferon-gamma assay results were included on the bar for 15 mm (arrow).
doi:10.1371/journal.pone.0000803.g002
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(median baseline interleukin-10 levels: 2.8 vs. 3.0 pg/mL for the
low (,0.07 IU/mL) and high ($0.07 IU/mL) baseline interferon-
gamma concentrations, respectively; p=0.263; Fig 3A). In contrast,
when exposed to either of the antigens, the median increase in the
interleukin-10 concentration was 0.1 pg/mL (range: 0 to 11.5 pg/
mL) in the 207 subjects. When the median increase in the
interferon-gamma concentration after exposure to the antigens
(0.01 IU/mL) was applied as a cutoff value, the median increase in
the interleukin-10 level was higher in the subgroup with the smaller
increase in interferon-gamma concentration (,0.01 IU/mL) than
in the subgroup with the larger increase in interferon-gamma
concentration($0.01 IU/mL)(0.3vs.0 pg/mL;p=0.004;Fig3B).
DISCUSSION
Historically, infection control policies in many hospitals have
recommended pre- and post-employment routine screening of
healthcare workers using the TST [2]; in accordance with this
recommendation, the TST has generally been required for
healthcare students at the start of their clinical studies [6]. In
Japan, however, repeated BCG vaccination has, until recently,
been performed during childhood if a negative TST result was
obtained while attending primary and junior high school.
Healthcare students and healthcare workers with negative TST
results at the time of their entry into clinical studies or at the time
of hiring might also receive BCG vaccinations in Japan, despite
no clear evidence of efficacy. Also, repeated testing using
tuberculin during their employment may further boost their
reaction to the TST. Thus, these factors may lead to a false-
positive TST result [9], producing quite discordant positive results
between the two tests both in a baseline screening setting for
healthcare students (1.4% vs. 27.5% for the whole blood test vs.
the TST; Table 2) and in a routine screening setting for Japanese
healthcare workers who have been employed for one or more
years (9.9% vs. 93.1%) [2].
To overcome the high false-positive TST results, several studies
have been conducted to assess the specificity of interferon-gamma
assays in low-risk healthcare students without active tuberculosis
[14–16]. In an Australian study, the whole blood assay was
performed in 60 medical students before and five months after
BCG immunization [15]. Of note, the specificity of the TST
Table 2. Agreement between whole blood interferon-gamma
assay and tuberculosis skin test results
......................................................................
TST Cutpoint, mm{
,Results*.$ 5 $10 $5
Positive TST/positive INF-c assay 3 (1.4%) 3 (1.4%) 3 (1.4%)
Negative TST/negative INF-c assay 36 (17.4%) 82 (39.6%) 147 (71.0%)
Positive TST/negative INF-c assay 163 (78.7%) 117 (56.5%) 52 (25.1%)
Negative TST/positive INF-c assay 0 0 0
Any TST/indeterminate INF-c assay 5 (2.4%) 5 (2.4%) 5 (2.4%)
Agreement, % 18.8 41.1 72.5
k 0.007 0.02 0.077
{Longest transverse diameter of induration. Abbreviations: TST=tuberculin skin
test, INF-c=interferon-gamma. *IFN-c assay cutpoint was at least 0.35 IU/mL.
doi:10.1371/journal.pone.0000803.t002
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Figure 3. Interleukin-10 concentrations stratified by interferon-gamma concentrations. The median baseline concentration of interferon-gamma
(negative control) was 0.07 IU/mL, while the median increase in the interferon-gamma concentration after exposure to either of the antigens was
0.01 IU/mL. A. Median baseline concentration of interleukin-10 (exposed to nil control) stratified by the baseline concentration of interferon-gamma
(exposed to nil control) (2.8 vs. 3.0 pg/mL for the low [,0.07 IU/mL] and high [$0.07 IU/mL] interferon-gamma concentrations; p=0.263). B. Median
increases in the interleukin-10 concentration stratified by increases in the interferon-gamma concentration after exposure to either of the antigens
(0.3 vs. 0 pg/mL for the smaller [,0.01 IU/mL] and larger [$0.01 IU/mL] increases in the interferon-gamma concentrations; p=0.004).
doi:10.1371/journal.pone.0000803.g003
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specificity (100%) was consistently observed for the whole blood
assay, irrespective of BCG immunization. A previous Japanese
study screened for tuberculosis infection in 213 nursing students
deemed to be truly free of infection [14], a young population that
was a quite similar cohort to ours. The study reported that 98% of
the students were negative for the whole blood assay, while
negative TST results (induration diameter#10mm) were observed
in only 35% of the same population. In our study, 96% and 40%
of the subjects had negative blood assay and TST results,
respectively (Table 2), suggesting that the results of both the
blood assay and the TST are almost reproducible. Both studies
also indicated that the blood assay rather than the TST
corresponded to the estimated cumulative prevalence of tubercu-
losis infection in young people in Japan [7].
In contrast, Pai et al. recently showed concordant results between
the two tests in Indian medical and nursing students at the start of
their clinical studies [16]. Unlike the above-mentioned studies
[14,15]. and ours, this Indian study suggested that BCG vaccination
had little impact on the TST results. Such minimal effect of the
BCG vaccination might be more likely to occur when the vaccine is
given to newborns only and in areas where the prevalence of
tuberculosis is high. Considering the tuberculosis control policies of
the Japanese government such as repeated BCG vaccination and
the relatively low estimated prevalence of tuberculosis infection in
Japan [7], the blood assay seems to be highly useful as a baseline
tuberculosis screening program for our healthcare students, in
whom the influence of BCG vaccination on the TST results is
unavoidable. To confirm its usefulness, further comprehensive
analyses are warranted, including a cost-effective study and a long-
term follow-up study, especially in the three subjects who had
positive blood assay results, the three subjects who had strong skin
reactions to PPD but negative blood assay results, and the five
subjects with indeterminate blood assay results. As a follow-up
study, the Indian research evaluated serial whole blood interferon-
gamma assays in medical and nursing students and found in their
follow-up study that this assay showed promise for serial testing,
despite the need to establish the optimal thresholds for distinguish-
ing new infections from nonspecific variations [16]. Further
research is also warranted to clarify the role of serial testing in
countries with lower rates of tuberculosis incidence [17,18].
One of our limitations is that we did not fully assess the
sensitivity of the blood assay because of few subjects with active
tuberculosis. The recent meta-analysis revealed the sensitivity of
this assay did not seem to be significantly higher than that of TST
despite its high specificity [9]. Indeed, one of our cases had
a negative blood assay result despite the previous close contact
with a tuberculosis patient and the strong TST reaction. Overall,
the discordant results between the TST and blood assay we
observed in this study might partly arise from its potentially low
sensitivity of the blood assay in addition to the high false positive
rate of the TST. These critical points should be further assessed in
carefully designed population studies.
We should note another obvious limitation in our study-the
possibility of bias due to a fairly high non-response rate. Only 207
(39%) of 536 students agreed to undergo both tests, and this may
have introduced a selection bias that affected the positive TST and
blood assay rates. Thus, our results should be carefully interpreted.
Interleukin-10 was first detected based on its cytokine synthesis
inhibitory activity, mainly on macrophages [19]. The complemen-
tary activity of interleukin-10 and Th1-mediated cytokines, in-
cluding interferon-gamma, may provide a mechanism for main-
taining a balance between the protective immune response and
excessive cellular activation. In this study, we also found evidence of
this relationship; after exposure to either ESAT-6 or CFP-10, the
change in the interleukin-10 concentration was inversely correlated
with that of interferon-gamma (p=0.004; Fig 3B), while no
association between the baseline (nil control) concentrations of the
two cytokines was seen (Fig 3A). Minion et al. reported comparable
data demonstrating that mice splenocytes vaccinated with Myco-
plasma hyopneumoniae surface antigen P71 alone produced higher
levels of interleukin-10, while those vaccinated with an ESAT-6:P71
fusion protein secreted higher levels of interferon-gamma but failed
to produce interleukin-10 [12]. Contrary to these results, Trajkovic
et al. showed that CFP-10 could stimulate the secretion of
interferon-gamma in mouse J774 cells in vitro, while CFP-10
pretreatment did not affect macrophage interleukin-10 synthesis
[13]. Thus, the response of interleukin-10 to these specific antigens
remains controversial in preclinical studies; however, our human
data might encourage further investigation of whether interleukin-
10 levels after exposure to specific antigens could be a useful tool for
the detection of tuberculosis infection. Our limitation is that only
one regulatory factor was assessed in relation to the interferon-
gamma assay; there are indeed many cytokines related to
homeostatic mechanisms balancing responses to specific tuberculo-
sis antigens [20]. Thus, a more comprehensive study of profile of
many other cytokines, rather than the assessment of a solitary
member like IL-10 should be done in the future.
In conclusion, we found inthis prospective study that the results of
an interferon-gamma assay were quite discordant with those for the
TST in a medical university setting, probably because of the
influence of BCG vaccination on the TST results. Given this
unavoidable influence of BCG vaccination and the relatively low
estimated prevalence of tuberculosis infection in Japan, the blood
assay seems to be useful as a baseline tuberculosis screening test for
Japanese healthcarestudents, despite the need for furtherresearches.
Additionally,wereport,forthefirsttime,thattheinterleukin-10level
after exposure to specific antigens was inversely associated with the
interferon-gamma level in the reported population.
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